Sunshine Hospitals Regulatory Affairs Executive Interview: Rounds, Questions and Preparation

What the job involves

Regulatory Affairs Executives in pharma and healthcare ensure that a company's products, documents, and processes comply with Indian and international regulations such as CDSCO, ICMR, and WHO guidelines. Day to day, they prepare and review dossiers, track regulatory submissions, maintain drug master files, and coordinate with R&D, QA, and legal teams. At fast-growing hospitals or small pharma firms, they may also handle clinical trial approvals, import licenses, and pharmacovigilance reporting.

Role and Technical Knowledge

1. 1

   What is the difference between CDSCO and ICMR in the Indian regulatory landscape?

   CDSCO approves drugs, clinical trials, and imports under the Drugs and Cosmetics Act, while ICMR issues ethical and research guidelines. Mention that both often work together for clinical trial approvals.

2. 2

   Explain the Common Technical Document (CTD) and its five modules.

   Cover modules 1 to 5: administrative, quality, non-clinical, clinical, and regional. Emphasise that Module 1 is region-specific and that eCTD is the electronic format.

3. 3

   What are the key differences between a New Drug Application (NDA) and an Abbreviated New Drug Application (ANDA)?

   NDA includes full safety and efficacy data, while ANDA relies on bioequivalence to an already approved drug. Mention that in India, CDSCO uses similar categories like new drug and generic applications.

4. 4

   How do ICH guidelines Q1 to Q10 help in regulatory affairs?

   Explain that Q1 covers stability, Q2 analytical validation, Q7 GMP, Q8 pharmaceutical development, and Q10 quality systems. Show how these guide submissions and inspections.

Practical Scenarios

1. 5

   You are preparing a dossier for a new drug submission, and one stability study report is missing. What do you do?

   Suggest checking if interim data can be submitted with a commitment to provide final data later. Mention coordinating with R&D and documenting the gap for the reviewer.

2. 6

   A hospital wants to import an unapproved medical device for emergency use. What regulatory steps apply?

   Talk about applying for an import license under CDSCO's Medical Device Rules, 2017, possibly with a no-objection certificate from the hospital ethics committee. Highlight documentation and timeline.

3. 7

   During an audit, you find that a batch record has an unsigned entry. How do you handle it?

   State that you would not backdate or alter the record. Instead, raise a deviation, investigate the root cause, and implement a corrective and preventive action (CAPA) as per GMP.

4. 8

   Your company receives a pharmacovigilance report of a serious adverse event from a patient. What is your immediate action?

   Mention that you must report it to CDSCO within 24 hours for serious events, fill the suspected adverse drug reaction form, and inform the drug safety team. Emphasise timeline and accuracy.

Behavioural and HR

1. 9

   Tell me about a time you had to meet a tight deadline with incomplete information.

   Use the STAR method: describe the situation, the action you took to gather what was available, and the result. Show that you prioritised and communicated clearly.

2. 10

   How do you handle a situation where a senior colleague asks you to skip a regulatory step to save time?

   Say you would politely explain the compliance risk and suggest an alternative that meets both timelines and regulations. Emphasise integrity and escalation if needed.

3. 11

   Why do you want to work in regulatory affairs rather than in clinical research or production?

   Connect your interest in documentation, law, and patient safety. Mention that regulatory affairs lets you ensure products reach patients safely and legally.

4. 12

   Where do you see yourself in three years in this role?

   Show ambition to learn global submissions (like US FDA or EMA) and take on more responsibility in dossier preparation or audits. Keep it realistic for a fast-growing company.

Company and Sector Awareness

1. 13

   What do you know about the regulatory challenges for a fast-growing hospital chain in India?

   Mention maintaining NABH accreditation, clinical trial approvals, and compliance with biomedical waste rules. Show awareness that small companies often lack dedicated regulatory teams.

2. 14

   How would you keep yourself updated with changing CDSCO circulars and notifications?

   List sources like the CDSCO website, pharma news portals, LinkedIn groups, and internal training. Mention setting up alerts and reading gazette notifications.

3. 15

   If you had to explain the importance of regulatory affairs to a new hospital administrator, what would you say?

   Focus on patient safety, legal penalties, and market access. Explain that without regulatory clearance, drugs and devices cannot be used or sold.